Eiichi Otsuka

Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality

Shigeo Fuji, Yoshitaka Inoue, Atae Utsunomiya et al. · Journal of Clinical Oncology · 2016 · 196 citations

Life Sciences, Hematology, Immunology +14

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation

Shigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue et al. · Haematologica · 2017 · 65 citations · Full text

Medicine, Immunology, Oncology +13

VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis

Shigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue et al. · Bone Marrow Transplantation · 2019 · 25 citations · Full text

Medicine, Oncology, Chemotherapy +9

Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis

Yuya Masuda, Kazuto Takeuchi, Toshio Kodama et al. · International Journal of Clinical Oncology · 2019 · 12 citations

Medicine, Oncology, Ophthalmology +8